Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""HISTOCOMPATIBILITY antigens"" wg kryterium: Temat


Tytuł :
Clustering of Major Histocompatibility Complex-Class I Molecules in Healthy and Cancer Colon Cells Revealed from Their Nanomechanical Properties.
Autorzy :
Moretti M; Single Molecule Imaging by Light Enhanced Spectroscopies Lab, King Abdullah University of Science and Technology, 23955-6900 Thuwal, Jeddah, Kingdom of Saudi Arabia.
La Rocca R; Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.
Perrone Donnorso M; Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.
Torre B; Single Molecule Imaging by Light Enhanced Spectroscopies Lab, King Abdullah University of Science and Technology, 23955-6900 Thuwal, Jeddah, Kingdom of Saudi Arabia.
Canale C; Department of Physics, University of Genova, Via Dodecaneso 33, 16146 Genova, Italy.
Malerba M; Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.
Das G; Department of Physics, Khalifa University, P. O. Box 127788 Abu Dhabi, United Arab Emirates.
Sottile R; Katharine Hsu Lab, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, United States.
Garofalo C; Department for Experimental and Clinical Medicine, University of Catanzaro, Viale Europa, 88100 Catanzaro, Italy.
Achour A; Science for Life Laboratory, Department of Medicine, Solna, Karolinska Institute, and Division of Infectious Diseases, Karolinska University Hospital, 17176 Solna, Stockholm, Sweden.
Kärre K; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Biomedicum Solnavägen 9, 17165 Solna, Stockholm, Sweden.
Carbone E; Dipartimento Medicina di Precisione, Università della Campania, via L. De Crecchio, 7, 80138 Naples, Italy.
Di Fabrizio E; Department of Applied Physics, Polytechnic University of Turin, Corso Duca degli Abruzzi, 24, 10129 Torino, Italy.
Pokaż więcej
Źródło :
ACS nano [ACS Nano] 2021 Apr 27; Vol. 15 (4), pp. 7500-7512. Date of Electronic Publication: 2021 Mar 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Histocompatibility Antigens Class I*
Neoplasms*
Antigen-Presenting Cells ; Cluster Analysis ; Colon ; Histocompatibility Antigens Class II ; Major Histocompatibility Complex
Czasopismo naukowe
Tytuł :
Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries.
Autorzy :
Liang C; Department of Bioinformatics, Biocenter, Am Hubland, University of Würzburg, 97074 Würzburg, Germany.
Bencurova E; Department of Bioinformatics, Biocenter, Am Hubland, University of Würzburg, 97074 Würzburg, Germany.
Psota E; Department of Pediatrics, Rheumatology and Special Immunology, University Hospital Würzburg, Pediatric Rheumatology/Special Immunology, Josef-Schneider-Str. 2, 97080 Würzburg, Germany.
Neurgaonkar P; Department of Bioinformatics, Biocenter, Am Hubland, University of Würzburg, 97074 Würzburg, Germany.
Prelog M; Department of Pediatrics, Rheumatology and Special Immunology, University Hospital Würzburg, Pediatric Rheumatology/Special Immunology, Josef-Schneider-Str. 2, 97080 Würzburg, Germany.
Scheller C; Institute of Virology and Immunobiology, University of Würzburg, Versbacher Str. 7, 97078 Würzburg, Germany.
Dandekar T; Department of Bioinformatics, Biocenter, Am Hubland, University of Würzburg, 97074 Würzburg, Germany.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Mar 05; Vol. 22 (5). Date of Electronic Publication: 2021 Mar 05.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19/*mortality
Histocompatibility Antigens Class II/*genetics
Histocompatibility Antigens Class II/*immunology
SARS-CoV-2/*chemistry
Viral Structural Proteins/*chemistry
Adaptive Immunity ; Alleles ; COVID-19/immunology ; COVID-19/transmission ; Computational Biology/methods ; Correlation of Data ; Epitopes, B-Lymphocyte/genetics ; Epitopes, B-Lymphocyte/immunology ; Epitopes, T-Lymphocyte/genetics ; Epitopes, T-Lymphocyte/immunology ; HLA Antigens/genetics ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/immunology ; Humans ; Mortality ; SARS-CoV-2/immunology ; Viral Structural Proteins/immunology
Czasopismo naukowe
Tytuł :
γδ TCR Recognition of MR1: Adapting to Life on the Flip Side.
Autorzy :
Willcox BE; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Birmingham, UK. Electronic address: .
Mohammed F; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Birmingham, UK.
Willcox CR; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Birmingham, UK.
Pokaż więcej
Źródło :
Trends in biochemical sciences [Trends Biochem Sci] 2020 Jul; Vol. 45 (7), pp. 551-553. Date of Electronic Publication: 2020 Apr 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Histocompatibility Antigens Class I*
Receptors, Antigen, T-Cell, gamma-delta*
Humans ; Ligands ; Minor Histocompatibility Antigens ; T-Lymphocytes/immunology
Czasopismo naukowe
Tytuł :
Understanding and modulating the MR1 metabolite antigen presentation pathway.
Autorzy :
McWilliam HEG; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC, 3010, Australia. Electronic address: .
Salio M; Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK. Electronic address: .
Pokaż więcej
Źródło :
Molecular immunology [Mol Immunol] 2021 Jan; Vol. 129, pp. 121-126. Date of Electronic Publication: 2020 Dec 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Antigen Presentation/*immunology
Histocompatibility Antigens Class I/*immunology
Mucosal-Associated Invariant T Cells/*immunology
Animals ; Antigens/immunology ; Autoimmunity/immunology ; Histocompatibility Antigens Class II/immunology ; Humans ; Ligands
Czasopismo naukowe
Tytuł :
How a tailor achieves the perfect fit.
Autorzy :
Colbert JD; Department of Pathology, University of Massachusetts, Worcester, Massachusetts 01655.
Rock KL; Department of Pathology, University of Massachusetts, Worcester, Massachusetts 01655. Electronic address: .
Pokaż więcej
Źródło :
The Journal of biological chemistry [J Biol Chem] 2020 May 22; Vol. 295 (21), pp. 7211-7212.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Comment
MeSH Terms :
Antigen Presentation*
Histocompatibility Antigens Class I*
Aminopeptidases ; Endoplasmic Reticulum ; Minor Histocompatibility Antigens ; Peptides
Czasopismo naukowe
Tytuł :
Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase.
Autorzy :
Kremer AN; Department of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Bausenwein J; Department of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Lurvink E; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
Kremer AE; Department of Internal Medicine 1, Gastroenterology, Pneumology and Endocrinology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Rutten CE; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
van Bergen CAM; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
Kretschmann S; Department of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
van der Meijden E; Department of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Honders MW; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
Mazzeo D; Division of Cell Signaling & Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Watts C; Division of Cell Signaling & Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Mackensen A; Department of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Falkenburg JHF; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
Griffioen M; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2020 Mar 11; Vol. 11, pp. 381. Date of Electronic Publication: 2020 Mar 11 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/immunology
Leukemia, Myeloid, Acute*/metabolism
Minor Histocompatibility Antigens*/genetics
Minor Histocompatibility Antigens*/immunology
Minor Histocompatibility Antigens*/metabolism
Cysteine Endopeptidases/*metabolism
Phosphotransferases (Alcohol Group Acceptor)/*genetics
Genetic Variation ; Graft vs Leukemia Effect/immunology ; Histocompatibility Antigens Class II/immunology ; Humans ; Phosphotransferases (Alcohol Group Acceptor)/immunology ; Phosphotransferases (Alcohol Group Acceptor)/metabolism
Czasopismo naukowe
Tytuł :
Detailed and atypical HLA-E peptide binding motifs revealed by a novel peptide exchange binding assay.
Autorzy :
Walters LC; Nuffield Department of Medicine Research Building, Roosevelt Drive, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
McMichael AJ; Nuffield Department of Medicine Research Building, Roosevelt Drive, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Gillespie GM; Nuffield Department of Medicine Research Building, Roosevelt Drive, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło :
European journal of immunology [Eur J Immunol] 2020 Dec; Vol. 50 (12), pp. 2075-2091. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Histocompatibility Antigens Class I/*immunology
Peptide Fragments/*immunology
Peptides/*immunology
Protein Binding/*immunology
Animals ; CD8-Positive T-Lymphocytes/immunology ; Cytomegalovirus/immunology ; Epitopes, T-Lymphocyte/immunology ; Genes, MHC Class I/immunology ; HIV/immunology ; Histocompatibility Antigens Class II/immunology ; Humans ; Macaca mulatta/immunology ; Simian Acquired Immunodeficiency Syndrome/immunology ; Simian Immunodeficiency Virus/immunology
Czasopismo naukowe
Tytuł :
TAPBPR promotes antigen loading on MHC-I molecules using a peptide trap.
Autorzy :
McShan AC; Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Devlin CA; Department of Biochemistry and Cancer Center at Illinois, University of Illinois, Urbana, IL, USA.
Morozov GI; Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Overall SA; Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA, USA.
Moschidi D; Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA, USA.
Akella N; Department of Biochemistry and Cancer Center at Illinois, University of Illinois, Urbana, IL, USA.
Procko E; Department of Biochemistry and Cancer Center at Illinois, University of Illinois, Urbana, IL, USA. .
Sgourakis NG; Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. .; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 May 26; Vol. 12 (1), pp. 3174. Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigen Presentation*
Histocompatibility Antigens Class I/*metabolism
Immunoglobulins/*metabolism
Membrane Proteins/*metabolism
Molecular Chaperones/*metabolism
Antigens/metabolism ; Cryoelectron Microscopy ; Crystallography, X-Ray ; Gene Knockout Techniques ; HEK293 Cells ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/isolation & purification ; Histocompatibility Antigens Class I/ultrastructure ; Humans ; Immunoglobulins/genetics ; Immunoglobulins/isolation & purification ; Immunoglobulins/ultrastructure ; Ligands ; Membrane Proteins/genetics ; Membrane Proteins/isolation & purification ; Membrane Proteins/ultrastructure ; Membrane Transport Proteins/genetics ; Membrane Transport Proteins/metabolism ; Molecular Chaperones/genetics ; Molecular Chaperones/ultrastructure ; Molecular Dynamics Simulation ; Mutagenesis, Site-Directed ; Mutation ; Peptide Library ; Protein Binding/genetics ; Protein Binding/immunology ; Recombinant Proteins/genetics ; Recombinant Proteins/isolation & purification ; Recombinant Proteins/metabolism ; Recombinant Proteins/ultrastructure
Czasopismo naukowe
Tytuł :
Strict Assembly Restriction of Peptides from Rabbit Hemorrhagic Disease Virus Presented by Rabbit Major Histocompatibility Complex Class I Molecule RLA-A1.
Autorzy :
Zhang Q; School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Liu K; Faculty of Health Sciences, University of Macau, Macau SAR, China.; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Yue C; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
Zhang D; School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Lu D; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
Xiao W; School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Liu P; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhao Y; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Gao G; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
Ding C; School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
Lyu J; School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China .; Zhejiang Provincial People's Hospital, Affiliated People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China.
Liu WJ; School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China .; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2020 Aug 17; Vol. 94 (17). Date of Electronic Publication: 2020 Aug 17 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hemorrhagic Disease Virus, Rabbit/*immunology
Hemorrhagic Disease Virus, Rabbit/*metabolism
Histocompatibility Antigens Class I/*chemistry
Histocompatibility Antigens Class I/*immunology
Peptides/*chemistry
Peptides/*immunology
Animals ; HLA Antigens/immunology ; Histocompatibility Antigens/immunology ; Histocompatibility Antigens Class I/genetics ; Models, Molecular ; Peptides/genetics ; Protein Binding/immunology ; Protein Conformation ; Rabbits ; Receptors, Antigen, T-Cell/metabolism ; Sequence Alignment ; T-Lymphocytes/immunology
Czasopismo naukowe
Tytuł :
SampPick: Selection of a Cohort of Subjects Matching a Population HLA Distribution.
Autorzy :
McGill JR; Hemostasis Branch, Division of Plasma Protein Therapeutics, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
Yogurtcu ON; Office of Biostatistics & Epidemiology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
Verthelyi D; Office of Biotechnology Products, Office of Product Quality, Center for Drugs Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
Yang H; Office of Biostatistics & Epidemiology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
Sauna ZE; Hemostasis Branch, Division of Plasma Protein Therapeutics, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2019 Dec 20; Vol. 10, pp. 2894. Date of Electronic Publication: 2019 Dec 20 (Print Publication: 2019).
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
HLA Antigens*/genetics
HLA Antigens*/immunology
Histocompatibility Antigens Class II*/genetics
Histocompatibility Antigens Class II*/immunology
Female ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/immunology ; Histocompatibility Testing ; Humans ; Male
Czasopismo naukowe
Tytuł :
Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10.
Autorzy :
Otoyama Y; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Arai J; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan; .
Goto K; Institut de Recherche sur les Maladies Virales et Hépatiques, INSERM, Strasbourg, France.
Nozawa H; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Nakagawa R; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Muroyama R; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Sugiura I; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Nakajima Y; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Kajiwara A; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Tojo M; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Ichikawa Y; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Uozumi S; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Shimozuma Y; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Uchikoshi M; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Sakaki M; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Kato N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yoshida H; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 May; Vol. 41 (5), pp. 2307-2320.
Typ publikacji :
Journal Article
MeSH Terms :
ADAM Proteins/*metabolism
ADAM10 Protein/*metabolism
Histocompatibility Antigens Class I/*metabolism
Membrane Proteins/*metabolism
Retinoids/*pharmacology
ADAM Proteins/antagonists & inhibitors ; ADAM Proteins/genetics ; ADAM10 Protein/antagonists & inhibitors ; ADAM10 Protein/genetics ; Biocatalysis/drug effects ; Cell Line, Tumor ; Cell Survival/drug effects ; Drug Synergism ; Hep G2 Cells ; Histocompatibility Antigens Class I/genetics ; Humans ; Membrane Proteins/antagonists & inhibitors ; Membrane Proteins/genetics ; Molecular Structure ; Phenylurea Compounds/pharmacology ; Pyridines/pharmacology ; RNA Interference ; Retinoid X Receptors/genetics ; Retinoid X Receptors/metabolism ; Retinoids/chemistry ; Solubility
Czasopismo naukowe
Tytuł :
The effect of anti‑HLA class I antibodies on the immunological properties of human glomerular endothelial cells and their modification by mTOR inhibition or GCN2 kinase activation.
Autorzy :
Eleftheriadis T; Department of Nephrology, Faculty of Medicine, University of Thessaly, Larissa 41110, Greece.
Pissas G; Department of Nephrology, Faculty of Medicine, University of Thessaly, Larissa 41110, Greece.
Crespo M; Nephrology Department, Hospital del Mar, Mar Health Park, Hospital del Mar Medical Research Institute, Barcelona 08003, Spain.
Filippidis G; Department of Nephrology, Faculty of Medicine, University of Thessaly, Larissa 41110, Greece.
Antoniadis N; Organ Transplant Unit, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki 54642, Greece.
Liakopoulos V; Department of Nephrology, Faculty of Medicine, University of Thessaly, Larissa 41110, Greece.
Stefanidis I; Department of Nephrology, Faculty of Medicine, University of Thessaly, Larissa 41110, Greece.
Pokaż więcej
Źródło :
Molecular medicine reports [Mol Med Rep] 2021 May; Vol. 23 (5). Date of Electronic Publication: 2021 Mar 24.
Typ publikacji :
Journal Article
MeSH Terms :
Graft Rejection/*immunology
Histocompatibility Antigens Class I/*immunology
Protein-Serine-Threonine Kinases/*genetics
TOR Serine-Threonine Kinases/*genetics
Antibodies, Anti-Idiotypic/immunology ; CD59 Antigens/genetics ; CD59 Antigens/immunology ; Cell Proliferation/drug effects ; Endothelial Cells/immunology ; Everolimus/pharmacology ; Graft Rejection/genetics ; Graft Rejection/pathology ; Histocompatibility Antigens Class I/genetics ; Humans ; Immunity, Humoral/genetics ; Immunity, Humoral/immunology ; Kidney Transplantation/adverse effects ; Mechanistic Target of Rapamycin Complex 1/immunology ; Membrane Cofactor Protein/genetics ; Membrane Cofactor Protein/immunology ; Primary Cell Culture ; Protein-Serine-Threonine Kinases/immunology ; Signal Transduction ; TOR Serine-Threonine Kinases/immunology ; von Willebrand Factor/genetics
Czasopismo naukowe
Tytuł :
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy.
Autorzy :
Verweij MC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Iyer R; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
John N; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Malouli D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Morrow D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Scholz I; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Womack J; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Abdulhaqq S; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Ventura AB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Selseth AN; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Berkemeier B; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Hull M; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Shao J; Population Sciences and Computational Biology Programs, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Sacha JB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Edlefsen PT; Population Sciences and Computational Biology Programs, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA. .
Früh K; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA. .
Pokaż więcej
Źródło :
Science (New York, N.Y.) [Science] 2021 Apr 30; Vol. 372 (6541). Date of Electronic Publication: 2021 Mar 25.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
CD8-Positive T-Lymphocytes/*immunology
Cytomegalovirus/*metabolism
Genetic Vectors/*metabolism
Histocompatibility Antigens Class I/*metabolism
Peptide Fragments/*metabolism
SAIDS Vaccines/*immunology
Animals ; Cell Line ; Cytomegalovirus/genetics ; Epitopes, T-Lymphocyte/immunology ; Fibroblasts/metabolism ; Genetic Vectors/genetics ; Histocompatibility Antigens Class I/genetics ; Ligands ; Macaca mulatta ; Peptide Fragments/genetics ; Protein Transport ; Simian Immunodeficiency Virus
Czasopismo naukowe
Tytuł :
Classical MHC expression by DP thymocytes impairs the selection of non-classical MHC restricted innate-like T cells.
Autorzy :
Georgiev H; Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, USA.; Institute of Immunology, Hannover Medical School, Hannover, D-30625, Germany.
Peng C; Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, USA.
Huggins MA; Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, USA.
Jameson SC; Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, USA.
Hogquist KA; Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Apr 16; Vol. 12 (1), pp. 2308. Date of Electronic Publication: 2021 Apr 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunity, Innate*
Histocompatibility Antigens Class I/*metabolism
Thymocytes/*immunology
Thymus Gland/*immunology
Animals ; Cell Differentiation/immunology ; Histocompatibility Antigens Class I/immunology ; Intracellular Signaling Peptides and Proteins/genetics ; Mice ; Mice, Transgenic ; Mucosal-Associated Invariant T Cells/immunology ; Natural Killer T-Cells/immunology ; Promyelocytic Leukemia Zinc Finger Protein/metabolism ; Thymocytes/metabolism ; Thymus Gland/cytology
Czasopismo naukowe
Tytuł :
COVID-19 in a lung transplant recipient: Exploring the diagnostic role of circulating exosomes and the clinical impact of advanced immunosuppression.
Autorzy :
Goodlet KJ; Department of Pharmacy Practice, College of Pharmacy, Midwestern University, Glendale, AZ, USA.
Bansal S; Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Arjuna A; Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Nailor MD; Department of Pharmacy Services, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Buddhdev B; Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Abdelrazek H; Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Mohamed H; Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Omar A; Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Walia R; Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Mohanakumar T; Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Tokman S; Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Pokaż więcej
Źródło :
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Apr; Vol. 23 (2), pp. e13480. Date of Electronic Publication: 2020 Oct 13.
Typ publikacji :
Case Reports
MeSH Terms :
Lung Transplantation*
COVID-19/*metabolism
Exosomes/*metabolism
Graft Rejection/*drug therapy
Histocompatibility Antigens Class II/*metabolism
Immunosuppressive Agents/*adverse effects
Spike Glycoprotein, Coronavirus/*metabolism
Aged ; Antilymphocyte Serum/therapeutic use ; Autoantigens/immunology ; Autoantigens/metabolism ; Bronchiolitis Obliterans ; COVID-19/immunology ; Collagen Type V/immunology ; Collagen Type V/metabolism ; Disease Progression ; Female ; Glucocorticoids/adverse effects ; Glucocorticoids/therapeutic use ; HLA Antigens/immunology ; HLA Antigens/metabolism ; Histocompatibility Antigens Class II/immunology ; Humans ; Immunosuppressive Agents/therapeutic use ; Methylprednisolone/adverse effects ; Methylprednisolone/therapeutic use ; SARS-CoV-2/immunology ; SARS-CoV-2/metabolism ; Spike Glycoprotein, Coronavirus/immunology ; Tubulin/immunology ; Tubulin/metabolism
Raport
Tytuł :
T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells.
Autorzy :
Lepore M; Immunocore Ltd Milton Park, Abingdon, United Kingdom. Electronic address: .
Lewinsohn DA; Department of Pediatrics, Oregon Health & Science University, Portland, OR, United States.
Lewinsohn DM; Department of Medicine, Oregon Health & Science University, Portland VA Medical Center, Portland, OR, United States. Electronic address: .
Pokaż więcej
Źródło :
Molecular immunology [Mol Immunol] 2021 Feb; Vol. 130, pp. 64-68. Date of Electronic Publication: 2020 Dec 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Histocompatibility Antigens Class I/*metabolism
Minor Histocompatibility Antigens/*metabolism
Mucosal-Associated Invariant T Cells/*metabolism
Receptors, Antigen, T-Cell/*immunology
T-Cell Antigen Receptor Specificity/*physiology
T-Lymphocyte Subsets/*immunology
Histocompatibility Antigens Class I/immunology ; Humans ; Immunity, Mucosal/immunology ; Minor Histocompatibility Antigens/immunology ; Mucosal-Associated Invariant T Cells/immunology ; Receptors, Antigen, T-Cell/physiology ; Receptors, Antigen, T-Cell, alpha-beta
Czasopismo naukowe
Tytuł :
Antigen specificities and functional properties of MR1-restricted T cells.
Autorzy :
De Libero G; University of Basel, Basel, Switzerland. Electronic address: .
Chancellor A; University of Basel, Basel, Switzerland.
Mori L; University of Basel, Basel, Switzerland.
Pokaż więcej
Źródło :
Molecular immunology [Mol Immunol] 2021 Feb; Vol. 130, pp. 148-153. Date of Electronic Publication: 2020 Dec 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigen Presentation*/genetics
Antigen Presentation*/immunology
T-Cell Antigen Receptor Specificity*/genetics
T-Cell Antigen Receptor Specificity*/immunology
Histocompatibility Antigens Class I/*metabolism
Minor Histocompatibility Antigens/*metabolism
T-Lymphocytes/*metabolism
Antigens, Bacterial/immunology ; Antigens, Bacterial/metabolism ; Histocompatibility Antigens Class I/chemistry ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/immunology ; Humans ; Ligands ; Lymphocyte Activation/genetics ; Lymphocyte Activation/immunology ; Minor Histocompatibility Antigens/chemistry ; Minor Histocompatibility Antigens/genetics ; Minor Histocompatibility Antigens/immunology ; Protein Binding ; Protein Structure, Tertiary ; T-Lymphocytes/immunology
Czasopismo naukowe
Tytuł :
In Translation: FcRn across the Therapeutic Spectrum.
Autorzy :
Qi T; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.
Cao Y; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Mar 17; Vol. 22 (6). Date of Electronic Publication: 2021 Mar 17.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Histocompatibility Antigens Class I/*chemistry
Histocompatibility Antigens Class I/*metabolism
Receptors, Fc/*chemistry
Receptors, Fc/*metabolism
Animals ; Antibodies, Monoclonal/metabolism ; Antibodies, Monoclonal/pharmacokinetics ; COVID-19/drug therapy ; Histocompatibility Antigens Class I/immunology ; Humans ; Immunoglobulin G/immunology ; Immunoglobulin G/metabolism ; Receptors, Fc/immunology ; Tissue Distribution/immunology
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
MATHLA: a robust framework for HLA-peptide binding prediction integrating bidirectional LSTM and multiple head attention mechanism.
Autorzy :
Ye Y; Shenzhen Neocura Biotechnology Co. Ltd., Shenzhen, 518055, China.; School of Computer Science and Technology, Heilongjiang University, Harbin, 150080, China.
Wang J; Shenzhen Neocura Biotechnology Co. Ltd., Shenzhen, 518055, China.
Xu Y; Shenzhen Neocura Biotechnology Co. Ltd., Shenzhen, 518055, China.
Wang Y; Shenzhen Neocura Biotechnology Co. Ltd., Shenzhen, 518055, China.
Pan Y; Shenzhen Neocura Biotechnology Co. Ltd., Shenzhen, 518055, China.
Song Q; Shenzhen Neocura Biotechnology Co. Ltd., Shenzhen, 518055, China.
Liu X; The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, 200031, China.
Wan J; Shenzhen Neocura Biotechnology Co. Ltd., Shenzhen, 518055, China. .
Pokaż więcej
Źródło :
BMC bioinformatics [BMC Bioinformatics] 2021 Jan 06; Vol. 22 (1), pp. 7. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Journal Article
MeSH Terms :
Histocompatibility Antigens Class I*/chemistry
Histocompatibility Antigens Class I*/metabolism
Neural Networks, Computer*
Peptides*/chemistry
Peptides*/metabolism
Protein Binding*
Computational Biology/*methods
Algorithms ; Humans ; Models, Statistical
Czasopismo naukowe
Tytuł :
NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers.
Autorzy :
Ong CEB; Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Private Bag 23, Hobart TAS 7000, Australia.
Patchett AL; Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Private Bag 23, Hobart TAS 7000, Australia.
Darby JM; Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Private Bag 23, Hobart TAS 7000, Australia.
Chen J; Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Private Bag 23, Hobart TAS 7000, Australia.; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Liu GS; Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Private Bag 23, Hobart TAS 7000, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Australia.
Lyons AB; Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia.
Woods GM; Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Private Bag 23, Hobart TAS 7000, Australia.
Flies AS; Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Private Bag 23, Hobart TAS 7000, Australia. .
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2021 Jul; Vol. 147 (7), pp. 1973-1991. Date of Electronic Publication: 2021 Apr 02.
Typ publikacji :
Journal Article
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Antigen Presentation/*immunology
Biomarkers, Tumor/*metabolism
Facial Neoplasms/*immunology
Histocompatibility Antigens Class I/*metabolism
Intracellular Signaling Peptides and Proteins/*metabolism
Animals ; Biomarkers, Tumor/genetics ; Facial Neoplasms/genetics ; Facial Neoplasms/metabolism ; Facial Neoplasms/pathology ; Histocompatibility Antigens Class I/genetics ; Intracellular Signaling Peptides and Proteins/genetics ; Marsupialia ; Transcriptome ; Tumor Cells, Cultured
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies